-
Advanced Grant (2025 – 2030). We have developed in vivo single-cell CRISPR technologies to screen for dozens of molecular factors in liver macrophages in vivo. We will apply these technologies to unravel
-
to neurodegenerative diseases of the central and peripheral nervous system, with an emphasis on understanding the genetic etiology and developing diagnostics and treatment methods for these diseases. Approaches range
Enter an email to receive alerts for web-development-"https:" "https:" "https:" positions